Characteristics of the study population
| Characteristics | ||
| No. of respondents | 260 | |
| Age | ||
| Mean (SD) | 68 | (10) |
| Range | 40–90 | |
| Male | 175 | 67% |
| Tumour stage | ||
| IA | 56 | (22%) |
| IB | 56 | (22%) |
| IIA | 10 | (4%) |
| IIB | 30 | (12%) |
| IIIA | 47 | (18%) |
| IIIB | 59 | (23%) |
| IV | 2 | (1%) |
| Initial treatment | ||
| Surgery | 114 | (44%) |
| Radiotherapy and chemotherapy | 68 | (26%) |
| Surgery and chemotherapy | 27 | (10%) |
| Radiotherapy | 22 | (9%) |
| Radiotherapy, chemotherapy and surgery | 19 | (7%) |
| Radiotherapy and surgery | 7 | (3%) |
| Chemotherapy | 3 | (1%) |
| Survival time (years) | ||
| Mean (SD) | 2.59 | (0.99) |
| Range | 0.82–4.76 | |
| Recurrence at time of completion | ||
| No | 189 | (73%) |
| Yes, local and/or regional | 16 | (6%) |
| Yes, distant metastases | 20 | (8%) |
| Unknown | 35 | (14%) |
Values are numbers (percentages) unless stated otherwise.